title: What is the future of CCR5 antagonists in rheumatoid arthritis?
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Takeuchi
authors.forename: Hideto
authors.initials: H
authors.lastname: Kameda
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003510:Cyclohexanes / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D003510:Cyclohexanes; D014230:Triazoles; D008727:Methotrexate